Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 5Neoplasms 4Colorectal Neoplasms 4Head and Neck Neoplasms 2Diabetes Mellitus 2Chronic Disease 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Sleep Wake Disorders 1Sleep Initiation and Maintenance Disorders 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Obesity 1Multiple Myeloma 1Mucositis 1Motor Activity 1Lymphoma 1Lymphoid Interstitial Pneumonia 1Lymphedema 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Hypertension 1Coronary Disease 1Cardiovascular Diseases 1

Interventions

Gemcitabine 47Cisplatin 32pembrolizumab 28Paclitaxel 13Docetaxel 13avelumab 12Mitomycin 12atezolizumab 11Nivolumab 11Cystectomy 10Carboplatin 9durvalumab 7Sunitinib 7apaziquone 6Doxorubicin 6BCG Vaccine 65-aminolevulinic acid hexyl ester 6Vinblastine 5Radiation 5Platinum 5Methotrexate 5Magnetic Resonance Spectroscopy 5Albumin-Bound Paclitaxel 5Taxes 4Standard of Care 4Sorafenib 4Radiotherapy 4Fluorouracil 4Erlotinib Hydrochloride 41,2-diaminocyclohexaneplatinum II citrate 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Urinary Bladder Neoplasms × Methods × Clear all
NCT04548193 2024-08-28

Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship

Roswell Park Cancer Institute

Phase 1 Completed
49 enrolled 12 charts
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡